The Supreme Court on Friday sought the government's response on a plea that the existing stocks of tuberculosis medicine be utilized for giving daily doses to patients.
Chief Justice Jagdish Singh Khehar and Justice D.Y. Chandrachd sought the government's response as PIL petitioner Raman Kakkar said that the government could well use its existing stocks for giving daily doses of tuberculosis medicine to the patients.
Kakkar, a Haryana-based medical officer associated with revised national TB control programme of India, is seeking the implementation of the government decision to administer TB doses to patients every day instead of the earlier practice of thrice a week.
He pointed out that TB medicines stocked with the government could be utilized for the present and arrangement for the future could be made in due course.
The court on Friday asked the Deputy Director General (TB) in the Health and Family Welfare Ministry to file an affidavit stating the government position on the plea.
In December 2016, the central government told the top court that it had decided to phase out the intermittent doses regime and switch over to daily doses.
The court was told that the switch-over would commence in five states.
Kakkar moved the top court for shifting to daily doses regime after studying 5,300 cases where he found the reappearance of the disease in patients who were treated and cured by giving doses thrice a week.
He found that in many cases, the resurfacing of the disease proved to be fatal.
--IANS
pk/pgh/mr
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
